CPA
INSM icon

Cowen Prime Advisors’s Insmed INSM Stock Holding History

Cowen Prime Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-200
Closed -$5K – 257
2015
Q2 		$5K Sell
200
-900
-82% -$20.4K ﹤0.01% 225
2015
Q1 		$23K Hold
1,100
– – 0.01% 217
2014
Q4 		$17K Hold
1,100
– – 0.01% 244
2014
Q3 		$14K Buy
+1,100
New +$16.6K 0.01% 242

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Cowen Prime Advisors's INSM Position: Q3 2015 in Review

Cowen Prime Advisors sold out of Insmed (INSM) in Q3 2015, closing a stake of 200 shares — an estimated $5K sold.

Cowen Prime Advisors first reported a position in INSM in Q3 2014 and held it in 4 quarters. The position peaked at $23K in Q1 2015. 119 funds tracked by Wall St. Rank hold INSM as of Q3 2015.

  • Cowen Prime Advisors reported no remaining Insmed position as of Q3 2015 after selling out during the quarter.
  • Cowen Prime Advisors sold 200 Insmed shares in Q3 2015, an estimated $5K.
  • Cowen Prime Advisors first reported a position in Insmed in Q3 2014 and held it in 4 quarters.
  • Cowen Prime Advisors's Insmed position peaked at $23K in Q1 2015.
  • 119 funds tracked by Wall St. Rank held Insmed as of Q3 2015.

Based on Cowen Prime Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.